Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014


#225034

76pages

GlobalData

$ 2500

In Stock


GlobalData's clinical trial report, Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Idiopathic Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Idiopathic Pulmonary Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables4
List of Figures 5

Introduction 6
Idiopathic Pulmonary Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Idiopathic Pulmonary Hypertension 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
United Therapeutics Corporation 31
Clinical Trial Overview of United Therapeutics Corporation 31
Actelion Ltd 32
Clinical Trial Overview of Actelion Ltd 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Northern Therapeutics, Inc. 34
Clinical Trial Overview of Northern Therapeutics, Inc. 34
Mast Therapeutics, Inc. 35
Clinical Trial Overview of Mast Therapeutics, Inc. 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Bayer AG 37
Clinical Trial Overview of Bayer AG 37
Clinical Trial Overview of Top Institutes / Government 38
Masih Daneshvari Hospital 38
Clinical Trial Overview of Masih Daneshvari Hospital 38
Royal Prince Alfred Hospital 39
Clinical Trial Overview of Royal Prince Alfred Hospital 39
Tehran University of Medical Sciences 40
Clinical Trial Overview of Tehran University of Medical Sciences 40
Medizinische Hochschule Hannover 41
Clinical Trial Overview of Medizinische Hochschule Hannover 41
Columbia University 42
Clinical Trial Overview of Columbia University 42
VU University Medical Center 43
Clinical Trial Overview of VU University Medical Center 43
Imperial College London 44
Clinical Trial Overview of Imperial College London 44
University of Pennsylvania 45
Clinical Trial Overview of University of Pennsylvania 45
Stanford University 46
Clinical Trial Overview of Stanford University 46
Five Key Clinical Profiles 47

Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76

Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Region, 2014* 7
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Idiopathic Pulmonary Hypertension Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Idiopathic Pulmonary Hypertension Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Idiopathic Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 31
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 32
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Northern Therapeutics, Inc., 2014* 34
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mast Therapeutics, Inc., 2014* 35
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 36
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 37
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Masih Daneshvari Hospital, 2014* 38
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Prince Alfred Hospital, 2014* 39
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 40
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medizinische Hochschule Hannover, 2014* 41
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 42
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 43
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 44
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 45
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 46

Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Idiopathic Pulmonary Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Idiopathic Pulmonary Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Idiopathic Pulmonary Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Idiopathic Pulmonary Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Idiopathic Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Idiopathic Pulmonary Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 75